Pharmafile Logo
Pharmafocus logo
Advanced Search

biologics

Showing 13 posts of 28 posts found.

Gilead buys manufacturing plant from Genentech

August 9, 2011
Manufacturing and Production Genentech, Gilead, biologics

Roche unit Genentech has agreed to sell a clinical manufacturing plant in California to Gilead Sciences. The 70,000 sq. ft. …

News

BMS licences potential first-in-class cancer biologic

July 7, 2011
Research and Development BMS, Cancer, biologics

Bristol-Myers Squibb has signed a $465 million deal for the rights to a potential first-in-class treatment for cancer. IPH2102 is …

News
Novo Nordisk

Novo Nordisk invests €134m in Danish facility

June 24, 2011
Manufacturing and Production Novo Nordisk, biologics, pharma manufacturing news

Novo Nordisk plans to invest almost 1 billion Danish kroner (134 million euros) in a new biologics manufacturing facility at …

News

Bayer invests 35m euros in biologics production

December 14, 2010
Manufacturing and Production Bayer, Germany, biologics, clinical trials supplies, pharma production

Bayer HealthCare is ramping up its biologics production capacity with the building of a new facility in Wuppertal, Germany, that …

News

GSK paves way for biopharmaceuticals growth

September 9, 2010
Research and Development GlaxoSmithKline, Lonza, biologics

GlaxoSmithKline has handed Swiss contract manufacturer Lonza a contract to produce clinical trial batches of five monoclonal antibodies that are …

News

Cancer Research UK facility celebrates first GMP batch

July 30, 2010
Manufacturing and Production Biotherapeutic, Cancer Research UK, biologics

Cancer Research UK has produced the first batch of product from its recently-completed biologics manufacturing unit, and hopes to release …

News
Spoon

Non-human sugars could compromise biologic drugs

July 28, 2010
Manufacturing and Production biologicals, biologics, manufacturing

Many of the biologic drugs on the market today contain sugar molecule components that in some patients could undermine their …

News

MedImmune: building a biologics future

April 19, 2010
Research and Development MedImmune, biologics

I paid my visit to MedImmune’s UK headquarters in Cambridge only days after its parent company AstraZeneca announced the closure …

Feature

Sanofi refocuses its French manufacturing capacity

April 1, 2010
Manufacturing and Production Dengue fever, Sanofi Pasteur, biologics

Sanofi-Aventis has set aside a 150 million euro ($200m) war chest to fund a major expansion of its biologic manufacturing …

News

UCB in ‘dynamic mode’ as work begins at new biologics research centre

July 31, 2009
Research and Development UCB, biologics

 UCB has opened its new biologics research centre in the UK, marking an investment of £25 million for the growing …

Feature

API market growth driven by biologics

May 13, 2009
Manufacturing and Production biologics

The global market for active pharmaceutical ingredients is being transformed as big pharma companies devote more and more resources to …

News

Consortium wins US biodefence contract

April 3, 2009
Manufacturing and Production biologics, vaccines

A consortium of US and UK companies has been awarded an $11 million grant from the US Government to speed …

News

Small and flexible: the manufacturing of tomorrow

March 24, 2009
Manufacturing and Production biologics

Biopharmaceutical manufacturing is likely to undergo a dramatic change over the next 20 years, with the today's facilities facing dramatic …

News

Latest content

FDA approves Amgen’s Imdelltra for extensive-stage small cell lung cancer

May 17, 2024

AstraZeneca shares results from phase 3 trial of COVID-19 prevention drug

May 17, 2024

GSK pledges £45m to Fleming Initiative to fight AMR

May 16, 2024

NeuroSense partners with PhaseV on upcoming phase 3 ALS trial

May 16, 2024

AstraZeneca adds new heart failure target through collaboration with BenevolentAI

May 15, 2024